Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: A prospective study

Respirology

Volumn 20, Issue 6, 2015, Pages 917-924

  Qi, Qian ^a   Wang, Wen ^b   Li, Tao ^a   Zhang, Yan ^a   Li, Yu ^a  

^a SHANDONG UNIVERSITY   (China)

^b Chengdu Second People's Hospital   (China)

Author keywords

aetiology; bronchiectasis; computed tomography; idiopathic; tuberculosis

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN;

ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBODY DETECTION; ARTICLE; BACTERIUM ISOLATION; BRONCHIECTASIS; BRONCHOSCOPY; CHINESE; CILIARY DYSKINESIA; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST; ETHNICITY; GENERAL HOSPITAL; HUMAN; IDIOPATHIC DISEASE; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION; LUNG LOBE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MULTICENTER STUDY (TOPIC); NONHUMAN; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RHEUMATIC DISEASE; SKIN TEST; TUBERCULOSIS; VARICOSIS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; FEMALE; KARTAGENER SYNDROME; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; BRONCHIECTASIS; CHINA; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; KARTAGENER SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, PULMONARY;

EID: 84937024217     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12574     Document Type: Article

References (37)

1. McShane PJ, Naureckas ET, Tino G, Strek ME,. Non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 2013; 188: 647-656.
2. Shoemark A, Ozerovitch L, Wilson R,. Aetiology in adult patients with bronchiectasis. Respir. Med. 2007; 101: 1163-1170.
3. Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, Flower CD, Bilton D, Keogan MT,. An investigation into causative factors in patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 2000; 162: 1277-1284.
4. Li AM, Sonnappa S, Lex C, Wong E, Zacharasiewicz A, Bush A, Jaffe A,. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur. Respir. J. 2005; 26: 8-14.
5. McShane PJ, Naureckas ET, Strek ME,. Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture. Chest 2012; 142: 159-167.
6. Pasteur MC, Bilton D, Hill AT, British Thoracic Society Non-CF Bronchiectasis Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65 (Suppl. 1): i1-58.
7. Habesoqlu MA, Uqurlu AO, Eyuboqlu FO,. Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis. Ann. Thorac. Med. 2011; 6: 131-136.
8. Zheng JP, Zhong NS,. Normative values of pulmonary function testing in Chinese adults. Chin. Med. J. (Engl) 2002; 115: 50-54.
9. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2010. Spirometry for health care providers. [Accessed 22 Dec 2014.] Available from URL: http://www.goldcopd.org/Other-resources/other-resources-gold-spirometry-guide.html
10. Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, et al. The bronchiectasis severity index: an international derivation and validation study. Am. J. Respir. Crit. Care Med. 2014; 189: 576-585.
11. Li N, Pei P, Bu DF, He B, Wang GF,. A novel CFTR mutation found in a Chinese patient with cystic fibrosis. Chin. Med. J. (Engl) 2006; 119: 103-109.
12. Li W, Sun L, Corey M, Zou F, Lee S, Cojocaru AL, Taylor C, Blackman SM, Stephenson AJ, Dorfman R, et al. Understanding the population structure of North American patients with cystic fibrosis. Clin. Genet. 2011; 79: 136-146.
13. Stead A, Douglas JG, Broadfoot CJ, Kaminski ER, Herriot R,. Humoral immunity and bronchiectasis. Clin. Exp. Immunol. 2002; 130: 325-330.
14. Chan HY, Yang YH, Yu HH, Chien YH, Chianq LL, Chianq BL,. Clinical features and outcomes of primary antibody deficiency: a 20-year follow-up. J. Formos. Med. Assoc. 2014; 113: 340-348.
15. Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, Moss R, Denning DW, ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin. Exp. Allergy 2013; 43: 850-873.
16. Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, Baktai G, Bartoloni L, Eber E, Escribano A, Haarman E, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur. Respir. J. 2009; 34: 1264-1276.
17. Aletaha D, Neoqi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62: 2569-2581.
18. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzqerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis. Care. Res. (Hoboken). 2012; 64: 797-808.
19. Villa-Forte A, European League Against Rheumatism, European Vasculitis Study Group. European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis. Curr. Opin. Rheumatol. 2010; 22: 49-53.
20. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, et al. American College of Rheumatology classification criteria for Sjogren syndrome: a data-driven, expert consensus approach in the Sjogren International Collaborative Clinical Alliance cohort. Arthritis. Care. Res. (Hoboken) 2012; 64: 475-487.
21. Anwar GA, McDonnell MJ, Worthy SA, Bourke SC, Afolabi G, Lordan J, Corris PA, Desoyza A, Middleton P, Ward C, et al. Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir. Med. 2013; 107: 1001-1007.
22. World Health Organization, 2014. Global tuberculosis report 2014. [Accessed 5 Jan 2015.] Available from URL: http://www.who.int/tb/publications/global-report/en/#.
23. Jordan TS, Spencer EM, Davies P,. Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology 2010; 15: 623-628.
24. Rammaert B, Goyet S, Tarantola A, Hem S, Rith S, Cheng S, Te V, Try PL, Guillard B, Vong S, et al. Acute lower respiratory infections on lung sequelae in Cambodia, a neglected disease in highly tuberculosis-endemic country. Respir. Med. 2013; 107: 1625-1632.
25. Baydarian M, Walter RN,. Bronchiectasis: introduction, etiology, and clinical features. Dis. Mon. 2008; 54: 516-526.
26. Goeminne PC, Scheers H, Decraene A, Seys S, Dupont LJ,. Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-section analysis of CT diagnosed bronchiectatic patients. Respir. Res. 2012; 13: 21. doi: 10.1186/1465-9921-13-21
27. Edmond K, Scott S, Korczak V, Ward C, Sanderson C, Theodoratou E, Clark A, Griffiths U, Rudan I, Campbell H,. Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS ONE 2012; 7: e31239. doi: 10.1371/journal.pone.0031239
28. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS,. Common variable immunodeficiency: a new look at an old disease. Lancet 2008; 372: 489-502.
29. Aghamohammadi A, Allahverdi A, Abolhassani H, Moazzami K, Alizadeh H, Gharagozlou M, Kalantari N, Sajedi V, Shafiei A, Parvaneh N, et al. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2010; 15: 289-295.
30. Dominguez O, Giner MT, Alsina L, Martin MA, Lozano J, Plaza AM,. Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol. An. Pediatr. (Barc.) 2012; 76: 262-267.
31. Duraisingham SS, Buckland M, Dempster J, Lorenzo L, Grigoriadou S, Longhurst HJ,. Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement. PLoS ONE 2014; 9: e100324. doi: 10.1371/journal.pone.0100324
32. Ortiz R, Cortes L, Cortes E, Medina H,. Malnutrition alters the rates of apoptosis in splenocytes and thymocyte subpopulations of rats. Clin. Exp. Immunol. 2009; 155: 96-106.
33. Vendrell M, de Gracia J, Rodriqo MJ, Cruz MJ, Alvarez A, Garcia M, Miravitlles M,. Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology. Chest 2005; 127: 197-204.
34. Rodrigo MJ, Vendrell M, Cruz MJ, Miravitlles M, Pascual C, Morell F, De Gracia J,. Utility of the antibody response to a conjugated Haemophilus influenzae type B vaccine for diagnosis of primary humoral immunodeficiency. Am. J. Respir. Crit. Care Med. 2000; 162: 1462-1465.
35. Li Z, Li JR, Gao JM,. Clinical evaluation of 136 inpatients with bronchiectasis in Peking Union Medical College Hospital. Zhongguo. Yi. Xue. Ke. Xue. Yuan. Xue. Bao. 2014; 36: 61-67.
36. Thomson RM, Yew WW,. When and how to treat pulmonary non-tuberculous mycobacterial diseases. Respirology 2009; 14: 12-26.
37. Zoumot Z, Boutou AK, Gill SS, van Zeller M, Hansell DM, Wells AU, Wilson R, Loebinger MR,. Mycobecterium avium complex infection in non-cystic fibrosis bronchiectasis. Respirology 2014; 19: 714-722.